GENEVA, Aug. 7 -- METAGENOMI THERAPEUTICS, INC. filed a patent application (US2026/013516) for “COMPOSITIONS AND METHODS FOR TARGETING THE DYSTROPHIN GENE”. With publication no. WO/2026/165489, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 9/88
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....